F

Fortress Biotech
D

FBIO

1.79000
USD
-0.03
(-1.38%)
مفتوح الان
حجم التداول
967
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
52,930,157
أصول ذات صلة
ABBV
ABBV
-0.320
(-0.17%)
184.550 USD
AMGN
AMGN
2.10
(0.73%)
290.19 USD
BIIB
BIIB
0.270
(0.21%)
126.840 USD
BMY
BMY
0.210
(0.45%)
47.065 USD
GILD
GILD
1.020
(0.94%)
109.040 USD
JNJ
JNJ
-1.150
(-0.76%)
149.470 USD
LLY
LLY
-18.34
(-2.34%)
765.17 USD
MRK
MRK
0.370
(0.47%)
79.370 USD
NVS
NVS
-0.050
(-0.04%)
115.830 USD
PFE
PFE
0.080
(0.33%)
23.920 USD
REGN
REGN
-3.58
(-0.70%)
509.85 USD
المزيد
الأخبار المقالات

العنوان: Fortress Biotech

القطاع: Healthcare
الصناعة: Biotechnology
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq,Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.